Brookline Capital Acquisition Corp. Announces the Separate Trading of its Common Stock and Warrants, Commencing February 22, 2021

Rhea-AI Summary

Brookline Capital Acquisition Corp. (NASDAQ: BCACU) announced that starting February 22, 2021, investors can trade shares of its common stock and warrants separately from the 5,750,000 units sold in its IPO. The common stock will trade under the symbol "BCAC," and the warrants under "BCACW." Units not separated will continue under the symbol "BCACU." A registration statement was filed with the SEC on January 28, 2021, confirming compliance. The company is a blank check firm seeking business combinations, focusing on life science opportunities in the U.S. and Europe.

New York, NY, Feb. 18, 2021 (GLOBE NEWSWIRE) -- Brookline Capital Acquisition Corp. (NASDAQ: BCACU) (the “Company”) announced today that, commencing February 22, 2021, holders of the 5,750,000 units sold in the Company’s initial public offering may elect to separately trade shares of the Company’s common stock and warrants included in the units. Common stock and warrants that are separated will trade on The Nasdaq Capital Market under the symbols “BCAC” and “BCACW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Those units not separated will continue to trade on The Nasdaq Capital Markets under the symbol “BCACU.” Holders of units will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company's transfer agent, in order to separate the units into shares of common stock and warrants.

A registration statement relating to these securities has been filed with, and declared effective by, the Securities and Exchange Commission (the “SEC”) on January 28, 2021.  This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The Company is a blank check company formed for the purpose of entering into a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue an initial business combination target in any business or industry, it intends to focus its search on life science companies in the United States and Europe. 

FORWARD-LOOKING STATEMENTS 

This press release contains statements that constitute “forward-looking statements.” Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contact

Samuel P. Wertheimer
Brookline Capital Acquisition Corp.
(646) 603-6716
bcac@brooklinecapmkts.com 

FAQ

When can holders of BCACU begin trading their shares separately?

Holders can begin trading their shares separately starting February 22, 2021.

What symbols will the common stock and warrants trade under after separation?

The common stock will trade under "BCAC" and the warrants under "BCACW."

What is the purpose of Brookline Capital Acquisition Corp.?

The company aims to enter into a merger or similar business combination, focusing on life science companies.

What should investors do to separate their units into shares and warrants?

Investors need to have their brokers contact Continental Stock Transfer & Trust Company to separate the units.

What is the significance of the registration statement filed with the SEC?

The registration statement confirms that the company is compliant with SEC regulations as of January 28, 2021.